Eli Lilly Files Q2 2024 10-Q, Details Debt
Ticker: LLY · Form: 10-Q · Filed: 2024-08-08T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, debt, pharmaceuticals
Related Tickers: LLY
TL;DR
LLY's Q2 10-Q is in, showing solid financials and various debt notes maturing through 2061. Looks good.
AI Summary
Eli Lilly and Company (LLY) filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial performance and position, including various debt instruments such as A718 Notes due June 1, 2025, and A1.625 Notes due June 2, 2026. The company's fiscal year ends on December 31st, and this report covers the second quarter of 2024.
Why It Matters
This filing provides investors with a detailed look at Eli Lilly's financial health and debt obligations as of the second quarter of 2024, crucial for understanding the company's financial stability and future investment potential.
Risk Assessment
Risk Level: low — The filing is a routine quarterly report and does not indicate any immediate or significant new risks.
Key Numbers
- 20240630 — Period End Date (This is the end date for the reporting period covered by the 10-Q.)
- 20240808 — Filing Date (This is the date the 10-Q was officially filed with the SEC.)
Key Players & Entities
- ELI LILLY & Co (company) — Filer
- 0000059478 (company) — Central Index Key
- 20240630 (date) — Period of Report
- 20240808 (date) — Filed as of Date
- A718 Notes due June 1, 2025 (dollar_amount) — Debt Instrument
- A1.625 Notes due June 2, 2026 (dollar_amount) — Debt Instrument
FAQ
What is the primary business of Eli Lilly & Co?
Eli Lilly & Co operates in the Pharmaceutical Preparations industry, SIC code 2834.
What is the fiscal year end for Eli Lilly & Co?
The company's fiscal year ends on December 31st.
What specific debt instruments are mentioned in the filing?
The filing mentions several debt instruments including A718 Notes due June 1, 2025, A1.625 Notes due June 2, 2026, A2.125 Notes due June 3, 2030, and others maturing up to 2061.
What is the SEC Act under which this filing is made?
This filing is made under the 1934 Act.
What is the SEC file number for Eli Lilly & Co?
The SEC file number for Eli Lilly & Co is 001-06351.
From the Filing
0000059478-24-000187.txt : 20240808 0000059478-24-000187.hdr.sgml : 20240808 20240808112854 ACCESSION NUMBER: 0000059478-24-000187 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 75 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240808 DATE AS OF CHANGE: 20240808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 241186877 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 10-Q 1 lly-20240630.htm 10-Q lly-20240630 FALSE 2024 Q2 0000059478 12/31 TRUE FALSE http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:EUR iso4217:JPY iso4217:GBP iso4217:CNY lly:patent iso4217:BRL 0000059478 2024-01-01 2024-06-30 0000059478 us-gaap:CommonClassAMember 2024-01-01 2024-06-30 0000059478 lly:A718NotesDueJune12025Member 2024-01-01 2024-06-30 0000059478 lly:A1.625NotesDueJune22026Member 2024-01-01 2024-06-30 0000059478 lly:A2.125NotesDueJune32030Member 2024-01-01 2024-06-30 0000059478 lly:A625NotesDue2031Member 2024-01-01 2024-06-30 0000059478 lly:A500NotesDue2033Member 2024-01-01 2024-06-30 0000059478 lly:A6.77NotesDueJanuary12036Member 2024-01-01 2024-06-30 0000059478 lly:A1625NotesDue2043Member 2024-01-01 2024-06-30 0000059478 lly:A1700NotesDue2049Member 2024-01-01 2024-06-30 0000059478 lly:A1125NotesDue2051Member 2024-01-01 2024-06-30 0000059478 lly:A1375NotesDue2061Member 2024-01-01 2024-06-30 0000059478 2024-08-05 0000059478 2024-04-01 2024-06-30 0000059478 2023-04-01 2023-06-30 0000059478 2023-01-01 2023-06-30 0000059478 2024-06-30 0000059478 2023-12-31 0000059478 us-gaap:CommonStockMember 2023-03-31 0000059478 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000059478 us-gaap:RetainedEarningsMember 2023-03-31 0000059478 us-gaap:TrustForBenefitOfEmployeesMember 2023-03-31 0000059478 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000059478 us-gaap:TreasuryStockCommonMember 2023-03-31 0000059478 us-gaap:NoncontrollingInterestMember 2023-03-31 0000059478 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000059478 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0000059478 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0000059478 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000059478 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000059478 us-gaap:CommonStockMember 2023-06-30 0000059478 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000059478 us-gaap:RetainedEarningsMember 2023-06-30 0000059478 us-gaap:TrustForBenefitOfEmployeesMember 2023-06-30 0000059478 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000059478 us-gaap:TreasuryStockCommonMember 2023-06-30 0000059478 us-gaap:NoncontrollingInterestMember 2023-06-30 0000059478 us-gaap:CommonStockMember 2024-03-31 0000059478 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000059478 us-gaap:RetainedEarningsMember 2024-03-31 0000059478 us-gaap:TrustForBenefitOfEmployeesMember 2024-03-31 0000059478 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000059478 us-gaap:TreasuryStockCommonMember 2024-03-31 0000059478 us-gaap:NoncontrollingInterestMember 2024-03-31 0000059478 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000059478 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0000059478 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000059478 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0